miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1

作者: Yuan Wang , Rachel Lieberman , Jing Pan , Qi Zhang , Meijun Du

DOI: 10.1186/S12943-016-0556-9

关键词: Docetaxel resistanceProstate cancerOncologyInternal medicineDocetaxelYAP1SEC23AMir-375Drug resistanceChemotherapyBiology

摘要: Background Treatment options for metastatic castrate-resistant prostate cancer (mCRPC) are limited and typically centered on docetaxel-based chemotherapy. We previously reported that elevated miR-375 levels were significantly associated with poor overall survival of mCRPC patients. In this study, we evaluated if induced chemo-resistance to docetaxel through regulating target genes drug resistance.

参考文章(31)
Qiqi Mao, Tao Quan, Bin Luo, Xuefeng Guo, Lei Liu, Qinghui Zheng, MiR-375 targets KLF4 and impacts the proliferation of colorectal carcinoma Tumor Biology. ,vol. 37, pp. 463- 471 ,(2016) , 10.1007/S13277-015-3809-0
Nahyun Choi, Jongmin Park, Jeon-Soo Lee, Jeehyun Yoe, Guk Yeol Park, Eunjeong Kim, Hyeongrin Jeon, Yong Mee Cho, Tae-Young Roh, Yoontae Lee, miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression Oncotarget. ,vol. 6, pp. 23533- 23547 ,(2015) , 10.18632/ONCOTARGET.4372
Jun-Wei Yan, Ju-Sheng Lin, Xing-Xing He, The emerging role of miR-375 in cancer. International Journal of Cancer. ,vol. 135, pp. 1011- 1018 ,(2014) , 10.1002/IJC.28563
Lekun Fang, Haoran Li, Lei Wang, Jun Hu, Tianru Jin, Jianping Wang, Burton B Yang, MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression Oncotarget. ,vol. 5, pp. 2974- 2987 ,(2014) , 10.18632/ONCOTARGET.1614
Juan He, Yanan Cao, Tingwei Su, Yiran Jiang, Lei Jiang, Weiwei Zhou, Cui Zhang, Weiqing Wang, Guang Ning, Downregulation of miR‐375 in aldosterone‐producing adenomas promotes tumour cell growth via MTDH Clinical Endocrinology. ,vol. 83, pp. 581- 589 ,(2015) , 10.1111/CEN.12814
Li-hui Yin, Xiao-qun Zheng, Hai-ying Li, Lai-xi Bi, Yi-fen Shi, Ai-fang Ye, Jian-bo Wu, Shen-meng Gao, Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm Leukemia Research. ,vol. 39, pp. 471- 478 ,(2015) , 10.1016/J.LEUKRES.2015.01.009
Xiaoyi Huang, Tiezheng Yuan, Meihua Liang, Meijun Du, Shu Xia, Rachel Dittmar, Dian Wang, William See, Brian A. Costello, Fernando Quevedo, Winston Tan, Debashis Nandy, Graham H. Bevan, Sherri Longenbach, Zhifu Sun, Yan Lu, Tao Wang, Stephen N. Thibodeau, Lisa Boardman, Manish Kohli, Liang Wang, Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer European Urology. ,vol. 67, pp. 33- 41 ,(2015) , 10.1016/J.EURURO.2014.07.035
Keitaro Kojima, Yasunori Fujita, Yoshinori Nozawa, Takashi Deguchi, Masafumi Ito, MiR‐34a attenuates paclitaxel‐resistance of hormone‐refractory prostate cancer PC3 cells through direct and indirect mechanisms The Prostate. ,vol. 70, pp. 1501- 1512 ,(2010) , 10.1002/PROS.21185
Namrata* Bhatnagar, Xia* Li, Sathish KR* Padi, Qunshu Zhang, MS Tang, Bin Guo, (* equal contribution), Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells Cell Death and Disease. ,vol. 1, ,(2010) , 10.1038/CDDIS.2010.85
Yuanming Shen, Jiansong Zhou, Yang Li, Feng Ye, Xiaoyun Wan, Weiguo Lu, Xing Xie, Xiaodong Cheng, miR-375 Mediated Acquired Chemo-Resistance in Cervical Cancer by Facilitating EMT PLOS ONE. ,vol. 9, ,(2014) , 10.1371/JOURNAL.PONE.0109299